High Yield Production of a Soluble Human Interleukin-3 Variant from E. coli with Wild-Type Bioactivity and Improved Radiolabeling Properties

• Timothy R. Hercus ,

  * E-mail: Tim.Hercus@health.sa.gov.au; jamesm@wehi.edu.au (JMM)

  Affiliation Centre for Cancer Biology, SA Pathology, Adelaide, South Australia, Australia

  ⨯
• Emma F. Barry,

  Affiliation Centre for Cancer Biology, SA Pathology, Adelaide, South Australia, Australia

  ⨯
• Mara Dottore,

  Affiliation Centre for Cancer Biology, SA Pathology, Adelaide, South Australia, Australia

  ⨯
• Barbara J. McClure,

  Affiliation Centre for Cancer Biology, SA Pathology, Adelaide, South Australia, Australia

  ⨯
• Andrew I. Webb,

  Affiliations Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia, Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia

  ⨯
• Angel F. Lopez,

  Affiliation Centre for Cancer Biology, SA Pathology, Adelaide, South Australia, Australia

  ⨯
• Ian G. Young,

  Affiliation Department of Molecular Bioscience, John Curtin School of Medical Research, The Australian National University, Canberra, Australian Capital Territory, Australia

  ⨯
• James M. Murphy

  * E-mail: Tim.Hercus@health.sa.gov.au; jamesm@wehi.edu.au (JMM)

  Affiliations Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia, Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia

  ⨯